BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

590 related articles for article (PubMed ID: 9930702)

  • 1. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28.
    Hutloff A; Dittrich AM; Beier KC; Eljaschewitsch B; Kraft R; Anagnostopoulos I; Kroczek RA
    Nature; 1999 Jan; 397(6716):263-6. PubMed ID: 9930702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cell co-stimulation through B7RP-1 and ICOS.
    Yoshinaga SK; Whoriskey JS; Khare SD; Sarmiento U; Guo J; Horan T; Shih G; Zhang M; Coccia MA; Kohno T; Tafuri-Bladt A; Brankow D; Campbell P; Chang D; Chiu L; Dai T; Duncan G; Elliott GS; Hui A; McCabe SM; Scully S; Shahinian A; Shaklee CL; Van G; Mak TW; Senaldi G
    Nature; 1999 Dec; 402(6763):827-32. PubMed ID: 10617205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional hierarchy and relative contribution of the CD28/B7 and ICOS/B7-H2 costimulatory pathways to T cell-mediated delayed-type hypersensitivity.
    Wong SC; Tan AH; Lam KP
    Cell Immunol; 2009; 256(1-2):64-71. PubMed ID: 19249753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical role of activation-inducible lymphocyte immunomediatory molecule/inducible costimulator in the effector function of human T cells: a comparative in vitro study of effects of its blockade and CD28 blockade in human beings and monkeys.
    Tajima N; Tezuka K; Tanaka M; Tanimoto M; Miyai A; Takeshima H; Watanabe Y
    Hum Immunol; 2008 Jul; 69(7):399-408. PubMed ID: 18638655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ICOS is critical for CD40-mediated antibody class switching.
    McAdam AJ; Greenwald RJ; Levin MA; Chernova T; Malenkovich N; Ling V; Freeman GJ; Sharpe AH
    Nature; 2001 Jan; 409(6816):102-5. PubMed ID: 11343122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of rat AILIM/ICOS, a novel T-cell costimulatory molecule, related to the CD28/CTLA4 family.
    Tezuka K; Tsuji T; Hirano D; Tamatani T; Sakamaki K; Kobayashi Y; Kamada M
    Biochem Biophys Res Commun; 2000 Sep; 276(1):335-45. PubMed ID: 11006126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-10 inhibits CD28 and ICOS costimulations of T cells via src homology 2 domain-containing protein tyrosine phosphatase 1.
    Taylor A; Akdis M; Joss A; Akkoç T; Wenig R; Colonna M; Daigle I; Flory E; Blaser K; Akdis CA
    J Allergy Clin Immunol; 2007 Jul; 120(1):76-83. PubMed ID: 17531298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of T:B cell interactions by the inducible costimulator molecule: does ICOS "induce" disease?
    Shilling RA; Bandukwala HS; Sperling AI
    Clin Immunol; 2006 Oct; 121(1):13-8. PubMed ID: 16790364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD28 and ICOS: similar or separate costimulators of T cells?
    van Berkel ME; Oosterwegel MA
    Immunol Lett; 2006 Jun; 105(2):115-22. PubMed ID: 16580736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion.
    Dong H; Zhu G; Tamada K; Chen L
    Nat Med; 1999 Dec; 5(12):1365-9. PubMed ID: 10581077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ICOS costimulates invariant NKT cell activation.
    Kaneda H; Takeda K; Ota T; Kaduka Y; Akiba H; Ikarashi Y; Wakasugi H; Kronenberg M; Kinoshita K; Yagita H; Okumura K
    Biochem Biophys Res Commun; 2005 Feb; 327(1):201-7. PubMed ID: 15629449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of costimulation in antibody deficiencies: ICOS and common variable immunodeficiency.
    Yong PF; Salzer U; Grimbacher B
    Immunol Rev; 2009 May; 229(1):101-13. PubMed ID: 19426217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ICOS is critical for T helper cell-mediated lung mucosal inflammatory responses.
    Gonzalo JA; Tian J; Delaney T; Corcoran J; Rottman JB; Lora J; Al-garawi A; Kroczek R; Gutierrez-Ramos JC; Coyle AJ
    Nat Immunol; 2001 Jul; 2(7):597-604. PubMed ID: 11429543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roquin differentiates the specialized functions of duplicated T cell costimulatory receptor genes CD28 and ICOS.
    Linterman MA; Rigby RJ; Wong R; Silva D; Withers D; Anderson G; Verma NK; Brink R; Hutloff A; Goodnow CC; Vinuesa CG
    Immunity; 2009 Feb; 30(2):228-41. PubMed ID: 19217324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AILIM/ICOS: its expression and functional analysis with monoclonal antibodies.
    Sakamoto S; Tezuka K; Tsuji T; Hori N; Tamatani T
    Hybrid Hybridomics; 2001; 20(5-6):293-303. PubMed ID: 11839247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of ICOS versus CD28 in antiviral immunity.
    Bertram EM; Tafuri A; Shahinian A; Chan VS; Hunziker L; Recher M; Ohashi PS; Mak TW; Watts TH
    Eur J Immunol; 2002 Dec; 32(12):3376-85. PubMed ID: 12432568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A distinct role for ICOS-mediated co-stimulatory signaling in CD4+ and CD8+ T cell subsets.
    Watanabe M; Hara Y; Tanabe K; Toma H; Abe R
    Int Immunol; 2005 Mar; 17(3):269-78. PubMed ID: 15668466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression level of costimulatory receptor ICOS is critical for determining the polarization of helper T cell function.
    Watanabe S; Ogawa S; Hara Y; Tanabe K; Toma H; Abe R
    Transpl Immunol; 2006 Apr; 15(4):255-63. PubMed ID: 16635747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and function of the co-stimulator H4/ICOS on activated T cells of patients with rheumatoid arthritis.
    Okamoto T; Saito S; Yamanaka H; Tomatsu T; Kamatani N; Ogiuchi H; Uchiyama T; Yagi J
    J Rheumatol; 2003 Jun; 30(6):1157-63. PubMed ID: 12784384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired interleukin-2 synthesis and T cell proliferation following antibody-mediated CD3 and CD2 or CD28 cross-linking in trans: evidence that T cell activation requires the engagement of costimulatory molecules within the immunological synapse.
    Watson CL; Furlong SJ; Hoskin DW
    Immunol Invest; 2008; 37(1):63-78. PubMed ID: 18214800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.